Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rilpivirine Roll-over Study in HIV-1 Infected Pediatric Patients
NCT02494986Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jul 2015
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of rilpivirine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Janssen Pharmaceutical. Started Jul 2015; status: completed.
02
Drugs
rilpivirine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02494986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02494986.